Scientists originally created these medications for patients with type 2 diabetes, but the US Food and Drug Administration (FDA) has also approved them for weight loss in certain people
It disrupts the balance of the tumor immune microenvironment by synergistically regulating immune cells, precisely antioxidant, and relieving immune suppression, forming a microenvironment conducive to anti-tumor immunity, thereby exerting a powerful cancer immunotherapy effect and showing good biocompatibility and tumor accumulation characteristics [427, 428]
Secondly, although our in vitro findings are encouraging, the systemic toxicity exhibited by free Polybia-MP1 in mice (renal failure, hemolysis, rhabdomyolysis, liver necrosis) presents a considerable obstacle to the in vivo application of the pDNA/Polybia-MP1 complex 27
That often includes answering plan-specific clinical questions and submitting supporting documentation such as chart notes, lab work or a letter of medical necessity, Zucchi says
Patients using these products should monitor blood glucose closely and discuss their use with healthcare providers